Forced Non-Medical Switching refers to the practice where insurance companies or pharmacy benefit managers (PBMs) require patients to switch from their prescribed medication or medical devices to a different, often cheaper, alternative. This practice can have significant negative impacts on patients with diabetes and their quality of life. A study by the Alliance for Patient Access (AfPA) found that such forced switches can lead to widespread damage to patient care and quality of life. The study surveyed 800 people, 27% of whom had diabetes, and revealed alarming trends. Many patients reported feeling frustrated, confused, helpless, and anxious about losing access to their necessary medications or supplies. The study also showed that two-thirds of respondents said the forced switch impacted their productivity at work, and over 40% said they were unable to care for their children, spouses, or other family members as needed. This practice not only affects the health and well-being of patients but also has economic consequences. There is significant advocacy against Non-Medical Switching, especially within the diabetes community, and efforts are being made at the state legislative level to address this issue. Patients and healthcare professionals are encouraged to raise their voices and be part of the solution by participating in advocacy efforts and staying informed about their rights and options.